Type 2 Diabetes Clinical Trials in Little Rock, Arkansas

4 studies are recruiting for type 2 diabetes in Little Rock, Arkansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

    This study aims to find out whether a study medicine called survodutide helps people control their blood sugar. Adults who live with type 2 diabetes and with a body mass index (BMI) of 23 kg/m2 or higher can join. The study has 3 parts. In each part the study compares survodutide with placebo. Surv…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Woodland International Research Group, Inc., Little Rock, Arkansas
    Locations
    121 in total
    Run by
    Boehringer Ingelheim

    See if you can join NCT07754461 on ClinicalTrials.gov

  2. A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

    This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight. The purpose of the study is to find out how safe and effective CagriSema is for body weight loss in these participants. Participants will receive eit…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Arkansas Clinical Research, Little Rock, Arkansas
    Locations
    303 in total
    Run by
    Novo Nordisk A/S

    See if you can join NCT07564414 on ClinicalTrials.gov

  3. A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

    The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Research Site, Little Rock, Arkansas
    Locations
    76 in total
    Run by
    AstraZeneca

    See if you can join NCT07606066 on ClinicalTrials.gov

  4. A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

    The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Participation in this study will last about 8 months.

    Stage
    Phase 3
    Ages
    10 to 17
    Site
    Arkansas Childrens Hospital, Little Rock, Arkansas
    Locations
    51 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06739122 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.